Clinical Liver Disease
Immunosuppression: Conventions and Controversies - Neil Mehta and Ryutaro Hirose – Article Reading
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:12
- More information
Informações:
Synopsis
Liver transplant recipients generally need lifelong immunosuppression - approximately 7 to 17 per cent of patients experience an episode of acute cellular rejection with 3 to 12 months of LT, respectively.